Survey of Ophthalmology
Volume 48, Issue 3 , Pages 295-313 , May 2003

Primary Open-Angle Glaucoma in Blacks: A Review

  • Lyne Racette, MA

      Affiliations

    • Glaucoma Center and Visual Function Laboratory, Department of Ophthalmology, University of California at San Diego, La Jolla, California, USA
    • ,
  • M.Roy Wilson, MD

      Affiliations

    • Department of Ophthalmology, Creighton University, Omaha, Nebraska, USA
    • ,
  • Linda M Zangwill, PhD

      Affiliations

    • Glaucoma Center and Visual Function Laboratory, Department of Ophthalmology, University of California at San Diego, La Jolla, California, USA
    • ,
  • Robert N Weinreb, MD

      Affiliations

    • Glaucoma Center and Visual Function Laboratory, Department of Ophthalmology, University of California at San Diego, La Jolla, California, USA
    • ,
  • Pamela A Sample, PhD

      Affiliations

    • Glaucoma Center and Visual Function Laboratory, Department of Ophthalmology, University of California at San Diego, La Jolla, California, USA
    • Corresponding Author InformationReprint address: Pamela A. Sample, PhD, Department of Ophthalmology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0946

References 

  1. AGIS . The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients. Ophthalmology. 1998;105:1137–1145
  2. AGIS . The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology. 1998;105:1146–1164
  3. AGIS . The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol. 2001;132:311–320
  4. Alward WL. The genetics of open-angle glaucoma: the story of GLC1A and myocilin. Eye. 2000;14:429–436
  5. Amaro H, Zambrana RE. Criollo, mestizo, mulato, LatiNegro, indigena, white, or black? The US Hispanic/Latino population and multiple responses in the 2000 census. Am J Public Health. 2000;90:1724–1727
  6. Armaly MF, Krueger DE, Maunder L, et al.  Biostatistical analysis of the collaborative glaucoma study (I. Summary report of the risk factors for glaucomatous visual-field defects). Arch Ophthalmol. 1980;98:2163–2171
  7. Bachman JA. Juvenile onset primary open-angle glaucoma: three case studies and review. J Am Optom Assoc. 1998;69:785–795
  8. Bartholomew RS. Glaucoma in a South African black population. S Afr Arch Ophthalmol. 1976;3:135–150
  9. Bassett MT. The pursuit of equity in health: reflections on race and public health data in Southern Africa. Am J Public Health. 2000;90:1690–1693
  10. Beck RW, Messner DK, Musch DC, et al.  Is there a racial difference in physiologic cup size?. Ophthalmology. 1985;92:873–876
  11. Becker B. Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1971;1:1–16
  12. Bengtsson B. Some factors affecting the distribution of intraocular pressure in a population. Acta Ophthalmol (Copenh). 1972;50:33–46
  13. Bengtsson B. Aspects of the epidemiology of chronic glaucoma. Acta Ophthalmol Suppl. 1981;146:1–48
  14. Benson WE, Brown GC, Tasman W. Diabetes and Its Ocular Complications. Philadelphia: WB Saunders; 1988;
  15. Boehmer U, Kressin NR, Berlowitz DR, et al.  Self-reported vs administrative race/ethnicity data and study results. Am J Public Health. 2002;92:1471–1472
  16. Borisuth NS, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol. 1999;10:112–116
  17. Bosworth CF, Sample PA, Gupta N, et al.  Motion automated perimetry identifies early glaucomatous field defects. Arch Ophthalmol. 1998;116:1153–1158
  18. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the ocular hypertension treatment study (OHTS). Ophthalmology. 2001;108:1779–1788
  19. Britton RJ, Drance SM, Schulzer M, et al.  The area of the neuroretinal rim of the optic nerve in normal eyes. Am J Ophthalmol. 1987;103:497–504
  20. Bucher PJ, Ijsselmuiden CB. Prevalence and causes of blindness in the northern Transvaal. Br J Ophthalmol. 1988;72:721–726
  21. Budde WM, Jonas JB, Martus P, Grundler AE. Influence of optic disc size on neuroretinal rim shape in healthy eyes. J Glaucoma. 2000;9:357–362
  22. Buhrmann RR, Quigley HA, Barron Y, et al.  Prevalence of glaucoma in a rural East African population. Invest Ophthalmol Vis Sci. 2000;41:40–48
  23. Cantor L, Berlin MS, Hodapp EA, et al.  Social and Economic Aspects of Glaucoma. Vol. 9. San Francisco: American Academy of Ophthalmology; 1997;
  24. Caprioli J, Miller JM. Optic disc rim area is related to disc size in normal subjects. Arch Ophthalmol. 1987;105:1683–1685
  25. Caprioli J, Miller JM. Videographic measurements of optic nerve topography in glaucoma. Invest Ophthalmol Vis Sci. 1988;29:1294–1298
  26. Caprioli J, Miller JM, Sears M. Quantitative evaluation of the optic nerve head in patients with unilateral visual field loss from primary open-angle glaucoma. Ophthalmology. 1987;94:1484–1487
  27. Carter-Edwards L, Bynoe MJ, Svetkey LP. Knowledge of diet and blood pressure among African Americans: use of focus groups for questionnaire development. Ethn Dis. 1998;8:184–197
  28. Chauhan BC. The value of high-pass resolution perimetry in glaucoma. Curr Opin Ophthalmol. 2000;11:85–89
  29. Chi T, Ritch R, Stickler D, et al.  Racial differences in optic nerve head parameters. Arch Ophthalmol. 1989;107:836–839
  30. Chirambo MC, Schwab L. Ophthalmology in Malawi. Arch Ophthalmol. 1989;107:1826–1829
  31. Chisholm IA, Stead S, Tan L, Melenchuk JW. Prognostic indicators in ocular hypertension. Can J Ophthalmol. 1980;15:4–8
  32. Cooper RS, Rotimi CN, Kaufman JS, et al.  Prevalence of NIDDM among populations of the African diaspora. Diabetes Care. 1997;20:343–348
  33. Coulehan JL, Helzlsouer KJ, Rogers KD, Brown SI. Racial differences in intraocular tension and glaucoma surgery. Am J Epidemiol. 1980;111:759–768
  34. Curtin B. The Myopias. Basic Science and Clinical Management. Philadelphia: Harper and Row; 1985;
  35. Damji KF. Advances in molecular genetics of glaucoma: a perspective for the clinician. Semin Ophthalmol. 1999;14:171–179
  36. Dandona L, Quigley HA, Brown AE, Enger C. Quantitative regional structure of the normal human lamina cribrosa. A racial comparison. Arch Ophthalmol. 1990;108:393–398
  37. Daubs JG, Crick RP. Effect of refractive error on the risk of ocular hypertension and open angle glaucoma. Trans Ophthalmol Soc UK,. 1981;101:121–126
  38. David R, Duval DON, Luntz MH. The prevalence and management of glaucoma in an African population. S Afr Arch Ophthalmol. 1983;10:55–62
  39. David R, Livingston D, Luntz MH. Ocular hypertension: a comparative follow-up of black and white patients. Br J Ophthalmol. 1978;62:676–678
  40. de Graaf AS, Lombard CJ, Hart GL. Standards for the assessment of visual evoked potentials in an ethnically heterogeneous adult population. S Afr Med J. 1985;67:243–245
  41. Deutsch A, Hiatt RL, Risser CF. Topical corticosteroid response in clinically normal eyes of Negroes forty years and older. Ann Ophthalmol. 1971;3:604–606
  42. Devgan U, Yu F, Kim E, Coleman AL. Surgical under treatment of glaucoma in black beneficiaries of medicare. Arch Ophthalmol. 2000;118:253–256
  43. Dielemans I, de Jong PT, Stolk R, et al.  Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology. 1996;103:1271–1275
  44. Dielemans I, Vingerling JR, Algra D, et al.  Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology. 1995;102:54–60
  45. Dohadwala AA, Munger R, Damji KF. Positive correlation between Tono-Pen intraocular pressure and central corneal thickness. Ophthalmology. 1998;105:1849–1854
  46. Drake MV, Wilson MR, Harris D, Goodwin L. Levobunolol compared to dipivefrin in African American patients with open angle glaucoma. J Ocul Pharmacol. 1993;9:91–95
  47. Egbert PR. Glaucoma in West Africa: a neglected problem. Br J Ophthalmol. 2002;86:131–132
  48. Fafowora OF, Osuntokun OO. Age-related eye disease in the elderly members of rural African community. East Afr Med J. 1997;74:435–437
  49. Feitl ME, Krupin T. Juvenile glaucoma. In:  Fraunfelder FT,  Roy FH editor. Ocular Therapy. Philadelphia: WB Saunders Company; 1995;p. 640–643
  50. Fingert JH, Heon E, Liebmann JM, et al.  Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8:899–905
  51. Ford ME, Tilley BC, McDonald PE. Social support among African-American adults with diabetes, (Part 2: A review). J Natl Med Assoc. 1998;90:425–432
  52. Foster A. Who will operate on Africa's 3 million curably blind people?. Lancet. 1991;337:1267–1269
  53. Foster A, Gilbert C. Epidemiology of childhood blindness. Eye. 1992;6(Pt 2):173–176
  54. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86:238–242
  55. Gasch AT, Wang P, Pasquale LR. Determinants of glaucoma awareness in a general eye clinic. Ophthalmology. 2000;107:303–308
  56. Gilbert C, Foster A. Blindness in children: control priorities and research opportunities. Br J Ophthalmol. 2001;85:1025–1027
  57. The Glaucoma Laser Trial (GLT) . 5. Subgroup differences at enrollment. Glaucoma Laser Trial Research Group. Ophthalmic Surg. 1993;24:232–240
  58. Glynn RJ, Gurwitz JH, Bohn RL, et al.  Old age and race as determinants of initiation of glaucoma therapy. Am J Epidemiol. 1993;138:395–406
  59. Goldberg I. How common is glaucoma worldwide?. In:  Weinreb RN,  Kitazawa Y,  Krieglstein G editor. Glaucoma in the 21st Century. London: Mosby International; 2000;p. 3–8
  60. Goodman AH. Why genes don't count (for racial differences in health). Am J Public Health. 2000;90:1699–1702
  61. Gordon MO, Beiser JA, Brandt JD, et al.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714–720 discussion 829–30
  62. Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 1999;117:573–583
  63. Grant WM, Burke JF. Why do some people go blind from glaucoma?. Ophthalmology. 1982;89:991–998
  64. Hansen FK. A clinical study of the normal human central corneal thickness. Acta Ophthalmol. 1971;49:82–89
  65. Harris LS, Galin MA. Effect of ocular pigmentation on hypotensive response to pilocarpine. Am J Ophthalmol. 1971;72:923–925
  66. Harris MI. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. Diabetes Care. 2001;24:454–459
  67. Harris MI, Klein R, Cowie CC, et al.  Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998;21:1230–1235
  68. Hiller R, Kahn HA. Blindness from glaucoma. Am J Ophthalmol. 1975;80:62–69
  69. Jamerson K, DeQuattro V. The impact of ethnicity on response to antihypertensive therapy. Am J Med. 1996;101:22S–32S
  70. Javitt JC, McBean AM, Nicholson GA, et al.  Undertreatment of glaucoma among black Americans. N Engl J Med. 1991;325:1418–1422
  71. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997;38:413–425
  72. Johnson M, Kass MA, Moses RA, Grodzki WJ. Increased corneal thickness simulating elevated intraocular pressure. Arch Ophthalmol. 1978;96:664–665
  73. Jonas JB, Gusek GC, Guggenmoos-Holzmann I, Naumann GO. Size of the optic nerve scleral canal and comparison with intravital determination of optic disc dimensions. Graefes Arch Clin Exp Ophthalmol. 1988;226:213–215
  74. Jonas JB, Gusek GC, Naumann GO. Optic disc morphometry in chronic primary open-angle glaucoma (I. Morphometric intrapapillary characteristics). Graefes Arch Clin Exp Ophthalmol. 1988;226:522–530
  75. Jonas JB, Gusek GC, Naumann GO. Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes. Invest Ophthalmol Vis Sci. 1988;29:1151–1158
  76. Jonas JB, Gusek GC, Naumann GO. Optic disk morphometry in high myopia. Graefes Arch Clin Exp Ophthalmol. 1988;226:587–590
  77. Jonas JB, Mardin CY, Schlotzer-Schrehardt U, Naumann GO. Morphometry of the human lamina cribrosa surface. Invest Ophthalmol Vis Sci. 1991;32:401–405
  78. Jonas JB, Schmidt AM, Muller-Bergh JA, et al.  Human optic nerve fiber count and optic disc size. Invest Ophthalmol Vis Sci. 1992;33:2012–2018
  79. Kahn HA, Leibowitz HM, Ganley JP, et al.  The Framingham Eye Study (II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study). Am J Epidemiol. 1977;106:33–41
  80. Kahn HA, Milton RC. Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol. 1980;98:2172–2177
  81. Kamel HK, Rodriguez-Saldana J, Flaherty JH, Miller DK. Diabetes mellitus among ethnic seniors: contrasts with diabetes in whites. Clin Geriatr Med. 1999;15:265–278
  82. Kass MA, Heuer DK, Higginbotham EJ, et al.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–713 discussion 829–30
  83. Katz IM, Berger ET. Effects of iris pigmentation on response of ocular pressure to timolol. Surv Ophthalmol. 1979;23:395–398
  84. Katz IM, Hubbard WA, Getson AJ, Gould AL. Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol. 1976;15:489–492
  85. Katz J, Gilbert D, Quigley HA, Sommer A. Estimating progression of visual field loss in glaucoma. Ophthalmology. 1997;104:1017–1025
  86. Katz J, Sommer A. Risk factors for primary open angle glaucoma. Am J Prev Med. 1988;4:110–114
  87. Katz J, Tielsch JM, Sommer A. Prevalence and risk factors for refractive errors in an adult inner city population. Invest Ophthalmol Vis Sci. 1997;38:334–340
  88. Klein BE, Klein R. Intraocular pressure and cardiovascular risk variables. Arch Ophthalmol. 1981;99:837–839
  89. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology. 1994;101:1173–1177
  90. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;33:2224–2228
  91. Klein BEK, Klein R, Moss SE. Intraocular pressure in diabetic persons. Ophthalmology. 1984;91:1356–1360
  92. Krieger N. Counting accountably: implications of the new approaches to classifying race/ethnicity in the 2000 census. Am J Public Health. 2000;90:1687–1689
  93. Krupin T, Patkin R, Kurata FK, et al.  Argon laser trabeculoplasty in black and white patients with primary open-angle glaucoma. Ophthalmology. 1986;93:811–816
  94. Kumanyika S, Savage DD, Ramirez AG, et al.  Beliefs about high blood pressure prevention in a survey of blacks and Hispanics. Am J Prev Med. 1989;5:21–26
  95. Kupin TH, Juzych MS, Shin DH, et al.  Adjunctive mitomycin C in primary trabeculectomy in phakic eyes. Am J Ophthalmol. 1955;119:30–39
  96. La Rosa FA, Gross RL, Orengo-Nania S. Central corneal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations. Arch Ophthalmol. 2001;119:23–27
  97. Lawson WB. The art and science of the psychopharmacotherapy of African Americans. Mt Sinai J Med. 1996;63:301–305
  98. Lawson WB. Clinical issues in the pharmacotherapy of African-Americans. Psychopharmacol Bull. 1996;32:275–281
  99. Leblanc B, Jezequel S, Davies T, et al.  Binding of drugs to eye melanin is not predictive of ocular toxicity. Regul Toxicol Pharmacol. 1998;28:124–132
  100. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112:821–829
  101. Leske MC, Connell AM, Wu SY, et al.  Distribution of intraocular pressure. The Barbados Eye Study. Arch Ophthalmol. 1997;115:1051–1057
  102. Leske MC, Connell AM, Wu SY, et al.  Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol. 1995;113:918–924
  103. Leske MC, Nemesure B, He Q, et al.  Patterns of open-angle glaucoma in the Barbados Family Study. Ophthalmology. 2001;108:1015–1022
  104. Leske MC, Podgor MJ. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol. 1983;118:280–287
  105. Leske MC, Wu SY, Nemesure B, Hennis A. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol. 2002;120:954–959
  106. Levene R, Wigdor A, Edelstein A, Baum J. Topical corticosteroid in normal patients and glaucoma suspects. Arch Ophthalmol. 1967;77:593–597
  107. Lewallen S, Courtright P. Blindness in Africa: present situation and future needs. Br J Ophthalmol. 2001;85:897–903
  108. Lichter PR, Musch DC, Gillespie BW, et al.  Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953
  109. Lotufo D, Ritch R, Szmyd L, Burris JE. Juvenile glaucoma, race, and refraction. JAMA. 1989;261:249–252
  110. Mansour AM. Racial variation of optic disc size. Ophthalmic Res. 1991;23:67–72
  111. Mansour AM. Racial variation of optic disc parameters in children. Ophthalmic Surg. 1992;23:469–471
  112. Mapstone R, Clark CV. Prevalence of diabetes in glaucoma. Br Med J (Clin Res Ed). 1985;291:93–95
  113. Martin MJ, Sommer A, Gold EB, Diamond EL. Race and primary open-angle glaucoma. Am J Ophthalmol. 1985;99:383–387
  114. Mason RP, Kosoko O, Wilson MR, et al.  National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies (Part I. Prevalence findings). Ophthalmology. 1989;96:1363–1368
  115. McLeod SD, West SK, Quigley HA, Fozard JL. A longitudinal study of the relationship between intraocular and blood pressures. Invest Ophthalmol Vis Sci. 1990;31:2361–2366
  116. Melikian HE, Lieberman TW, Leopold IH. Ocular pigmentation and pressure and outflow responses to pilocarpine and epinephrine. Am J Ophthalmol. 1971;72:70–73
  117. Menon IA, Wakeham DC, Persad SD, et al.  Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes. J Ocul Pharmacol. 1992;8:35–42
  118. Mermoud A, Salmon JF, Murray AD. Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol. 1993;116:72–78
  119. Merritt JC. Glaucoma blindness in African Americans: have 55 years of therapies, technologies, and talent altered blindness rates?. J Natl Med Assoc. 1996;88:809–819
  120. Meyer T, Howland HC. How large is the optic disc? Systematic errors in fundus cameras and topographers. Ophthalmic Physiol Opt. 2001;21:139–150
  121. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology. 1997;104:712–718
  122. Morgan RW, Drance SM. Chronic open-angle glaucomaand ocular hypertension. An epidemiological study. Br J Ophthalmol. 1975;59:211–215
  123. Morris DA, Peracha MO, Shin DH, et al.  Risk factors for early filtration failure requiring suture release after primary glaucoma triple procedure with adjunctive mitomycin. Arch Ophthalmol. 1999;117:1149–1154
  124. Moser CL, Martin-Baranera M, Vega F, et al.  Survey of blindness and visual impairment in Bioko, Equatorial Guinea. Br J Ophthalmol. 2002;86:257–260
  125. Muñoz B, West SK. Blindness and visual impairment in the Americas and the Caribbean. Br J Ophthalmol. 2002;86:498–504
  126. Muñoz B, West SK, Rubin GS, et al.  Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118:819–825
  127. Munro-Faure AD, Beilin LJ, Bulpitt CJ, et al.  Comparison of black and white patients attending hypertension clinics in England. Br Med J. 1979;1:1044–1047
  128. Musch DC, Lichter PR, Guire KE, Standardi CL. The Col-laborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653–662
  129. Négrel AD, Avognon Z, Minassian DC, et al.  La cécité au Bénin. Med Trop. 1995;55:409–414
  130. Nielsen NV. The prevalence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus. An epidemiological study of diabetes mellitus on the island of Falster, Denmark. Acta Ophthalmol (Copenh). 1983;61:662–672
  131. Olateju SO, Ajayi AA. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers. Eye. 1999;13:758–763
  132. Ontiveros JA, Black SA, Jakobi PL, Goodwin JS. Ethnicvariation in attitudes toward hypertension in adults ages 75 and older. Prev Med. 1999;29:443–449
  133. Perkins ES, Phelps CD. Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction. Arch Ophthalmol. 1982;100:1464–1467
  134. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389–393
  135. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma (II. The site of injury and susceptibility to damage). Arch Ophthalmol. 1981;99:635–649
  136. Quigley HA, Brown AE, Morrison JD, Drance SM. The size and shape of the optic disc in normal human eyes. Arch Ophthalmol. 1990;108:51–57
  137. Quigley HA, Buhrmann RR, West SK, et al.  Long term results of glaucoma surgery among participants in an east African population survey. Br J Ophthalmol. 2000;84:860–864
  138. Quigley HA, Coleman AL, Dorman-Pease ME. Larger optic nerve heads have more nerve fibers in normal monkey eyes. Arch Ophthalmol. 1991;109:1441–1443
  139. Quigley HA, Enger C, Katz J, et al.  Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol. 1994;112:644–649
  140. Quigley HA, Hohman RM, Addicks EM, et al.  Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol. 1983;95:673–691
  141. Quigley HA, Tielsch JM, Katz J, Sommer A. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. Am J Ophthalmol. 1996;122:355–363
  142. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83–91
  143. Rabb MF, Gagliano DA, Sweeney HE. Diabetic retinopathy in blacks. Diabetes Care. 1990;13:1202–1206
  144. Rahmani B, Tielsch JM, Katz J, et al.  The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology. 1996;103:1721–1726
  145. Reynolds DC. Relative risk factors in chronic open-angle glaucoma: an epidemiological study. Am J Optom Physiol Opt. 1977;54:116–120
  146. Rezaie T, Child A, Hitchings R, et al.  Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295:1077–1079
  147. Rosenthal AR, Perkins ES. Family studies in glaucoma. Br J Ophthalmol. 1985;69:664–667
  148. Rotchford AP, Johnson GJ. Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. Arch Ophthalmol. 2002;120:471–478
  149. Rubin GS, West SK, Muñoz B, et al.  A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci. 1997;38:557–568
  150. Rutledge DR. Race and hypertension. What is clinically relevant?. Drugs. 1994;47:914–932
  151. Salmon JF, Mermoud A, Ivey A, et al.  The prevalence of primary angle closure glaucoma and open angle glaucoma in Mamre, western Cape, South Africa. Arch Ophthalmol. 1993;111:1263–1269
  152. Sample PA. Short-wavelength automated perimetry: it's role in the clinic and for understanding ganglion cell function. Prog Retin Eye Res. 2000;19:369–383
  153. Sanders RJ, Wilson MR. Diabetes-related eye disorders. J Natl Med Assoc. 1993;85:104–108
  154. Schwab L, Kagame K. Blindness in Africa: Zimbabwe schools for the blind survey. Br J Ophthalmol. 1993;77:410–412
  155. Schwab L, Steinkuller PG. Surgical treatment of open angle glaucoma is preferable to medical management in Africa. Soc Sci Med. 1983;17:1723–1727
  156. Schwartz AL, Love DC, Schwartz MA. Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma. Arch Ophthalmol. 1985;103:1482–1484
  157. Seddon JM, Schwartz B, Flowerdew G. Case-control study of ocular hypertension. Arch Ophthalmol. 1983;101:891–894
  158. Shin DH, Becker B, Kolker AE. Family history in primary open-angle glaucoma. Arch Ophthalmol. 1977;95:598–600
  159. Shin DH, Ren J, Juzych MS, et al.  Primary glaucoma triple procedure in patients with primary open-angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtration failure. Am J Ophthalmol. 1998;125:346–352
  160. Silva JC, Bateman JB, Contreras F. Eye disease and care in Latin America and the Caribbean. Surv Ophthalmol. 2002;47:267–274
  161. Smith GD. Learning to live with complexity: ethnicity, socioeconomic position, and health in Britain and the United States. Am J Public Health. 2000;90:1694–1698
  162. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419–1428
  163. Sommer A, Tielsch JM, Katz J, et al.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991;109:1090–1095
  164. Sommer A, Tielsch JM, Katz J, et al.  Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325:1412–1417
  165. Sondik EJ, Lucas JW, Madans JH, Smith SS. Race/ethnicity and the 2000 census: implications for public health. Am J Public Health. 2000;90:1709–1713
  166. Stoilov I, Akarsu AN, Alozie I, et al.  Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet. 1998;62:573–584
  167. Stone EM, Fingert JH, Alward WL, et al.  Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668–670
  168. American Academy of Ophthalmology . Glaucoma, in basic clinical science course (Section 10). San Francisco: American Academy of Ophthalmology; 2001; p.11
  169. Thylefors B, Negrel AD. The global impact of glaucoma. Bull World Health Organ. 1994;72:323–326
  170. Thylefors B, Negrel AD, Pararajasegaram R. Epidemiologic aspects of global blindness prevention. Curr Opin Ophthalmol. 1992;3:824–834
  171. Tielsch JM, Katz J, Quigley HA, et al.  Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995;102:48–53
  172. Tielsch JM, Katz J, Sommer A, et al.  Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol. 1994;112:69–73
  173. Tielsch JM, Katz J, Sommer A, et al.  Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol. 1995;113:216–221
  174. Tielsch JM, Sommer A, Katz J, et al.  Socioeconomic status and visual impairment among urban Americans. Baltimore Eye Survey Research Group. Arch Ophthalmol. 1991;109:637–641
  175. Tielsch JM, Sommer A, Katz J, et al.  Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266:369–374
  176. Tjon-Fo-Sang MJ, Lemij HG. Retinal nerve fiber layer measurements in normal black subjects as determined with scanning laser polarimetry. Ophthalmology. 1998;105:78–81
  177. Tomlinson A, Phillips CI. Applanation tension and axial length of the eyeball. Br J Ophthalmol. 1970;54:548–553
  178. Tsai CS, Zangwill L, Gonzalez C, et al.  Ethnic differences in optic nerve head topography. J Glaucoma. 1995;4:248–257
  179. Varma R, Hilton SC, Tielsch JM, et al.  Neural rim area declines with increased intraocular pressure in urban Americans. Arch Ophthalmol. 1995;113:1001–1005
  180. Varma R, Tielsch JM, Quigley HA, et al.  Race-, age-, gender-,and refractive error-related differences in the normal optic disc. Arch Ophthalmol. 1994;112:1068–1076
  181. Verrey JD, Foster A, Wormald R, Akuamoa C. Chronic glaucoma in northern Ghana—a retrospective study of 397 patients. Eye. 1990;4(Pt 1):115–120
  182. Vesti E, Trick GL. Diabetes can alter the interpretation of visual dysfunction in ocular hypertension. Ophthalmology. 1996;103:1419–1425
  183. Wallace J, Lovell HG. Glaucoma and intraocular pressure in Jamaica. Am J Ophthalmol. 1969;67:93–100
  184. Wang F, Javitt JC, Tielsch JM. Racial variations in treatment for glaucoma and cataract among Medicare recipients. Ophthalmic Epidemiol. 1997;4:89–100
  185. Waters MC. Immigration, intermarriage, and the challenges of measuring racial/ethnic identities. Am J Public Health. 2000;90:1735–1737
  186. Weinreb RN, Bowd C, Greenfield DS, Zangwill LM. Measurement of the magnitude and axis of corneal polarization with scanning laser polarimetry. Arch Ophthalmol. 2002;120:901–906
  187. Whitfield R, Schwab L, Ross-Degnan D, et al.  Blindness and eye disease in Kenya: ocular status survey results from the Kenya Rural Blindness Prevention Project. Br J Ophthalmol. 1990;74:333–340
  188. Wilensky JT, Gandhi N, Pan T. Racial influences in open-angle glaucoma. Ann Ophthalmol. 1978;10:1398–1402
  189. Williams DR. Race and health: basic questions, emerging directions. Ann Epidemiol. 1997;7:322–333
  190. Williams DR, Jackson JS. Race/ethnicity and the 2000 census: recommendations for African American and other black populations in the United States. Am J Public Health. 2000;90:1728–1730
  191. Wilson MR, Baker R. Prognostic factors for glaucoma filtration surgery. J Glaucoma. 1993;2:223–226
  192. Wilson MR, Hertzmark E, Walker AM, et al.  A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol. 1987;105:1066–1071
  193. Wilson MR, Kosoko O, Cowan CL, et al.  Progression of visual field loss in untreated glaucoma patients and suspects in St. Lucia, West Indies. Am J Ophthalmol. 2002;134:399–405
  194. Wilson MR, Mansour M, Ross-Degnan D, et al.  Prevalence and causes of low vision and blindness in the Extreme North Province of Cameroon, West Africa. Ophthalmic Epidemiol. 1996;3:23–33
  195. Wilson R, Richardson TM, Hertzmark E, Grant WM. Race as a risk factor for progressive glaucomatous damage. Ann Ophthalmol. 1985;17:653–659
  196. Wolfs RC, Klaver CC, Ramrattan RS, et al.  Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol. 1998;116:1640–1645
  197. Wormald RP, Basauri E, Wright LA, Evans JR. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London. Eye. 1994;8:315–320
  198. Wu SY, Nemesure B, Leske MC. Refractive errors in a black adult population: the Barbados Eye Study. Invest Ophthalmol Vis Sci. 1999;40:2179–2184
  199. Yorston D, Khaw PT. A randomised trial of the effect of intraoperative 5-FU on the outcome of trabeculectomy in east Africa. Br J Ophthalmol. 2001;85:1028–1030
  200. Zerihun N, Mabey D. Blindness and low vision in Jimma Zone, Ethopia: results of a population-based survey. Ophthalmic Epidemiol. 1997;4:19–26
  201. Zimmerman TJ, Kaufman HE. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol. 1977;95:601–604

☆ The authors wish to thank Dr. Tarek El Beltagi for reviewing earlier versions of the manuscript and Ms. Shannon Kleinhandler for her assistance. This article was supported by NIH grants EY08208 (PAS) and EY11008 (LZ), and the Glaucoma Research Foundation (PAS). The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(03)00028-6

doi: 10.1016/S0039-6257(03)00028-6

Survey of Ophthalmology
Volume 48, Issue 3 , Pages 295-313 , May 2003

Article Tools